Events Search and Views Navigation

Event Views Navigation

Filters

Changing any of the form inputs will cause the list of events to refresh with the filtered results.

Current

    • Opthea Key Opinion Leader Event on Sozinibercept (OPT-302) in Wet Age-Related Macular Degeneration

    Join Opthea Limited, a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, for a…
    TIME: 10:00 AM EDT
    LOCATION: Virtual
    View Details

    • Humacyte Virtual KOL Event on Hemodialysis Access: A Crossroads of Care – Confronting Complications, Challenges, and Costs with Innovation

    Join Humacyte for a virtual KOL event, featuring Timmy Lee, MD, MSPH (University of Alabama at Birmingham) and Prabir Roy-Chaudhury MD, PhD, FRCP…
    TIME: 8:00 AM EDT
    LOCATION: Virtual
    View Details

    3rd Annual VISTA Symposium: VISTA – Clinical updates and biological insights on a promising new target in cancer immunotherapy

    With anticipation building for the first clinical readouts expected later in 2024, join Hummingbird Bioscience and Dartmouth's Geisel School of…
    TIME: 11:00 AM EDT
    LOCATION: Virtual
    View Details

    Praxis Precision Medicines to Host PRAX-628 Program Update

    Please join Praxis Precision Medicines for a virtual update on its PRAX-628 Program. Praxis’ management will lead the discussion and…
    TIME: 8:00 AM EDT
    LOCATION: Virtual
    View Details

    Astria Therapeutics ALPHA-STAR Ph 1b/2 Results Call

    Details to follow.
    TIME: 8:30 AM EDT
    LOCATION: Virtual
    View Details

    Carmell Unveiling the Secretome: On the Eve of Product Launch

    Join us to learn how Carmell Corp (Nasdaq: CTCX) is bringing the biggest technological revolution in regenerative skin and haircare to the…
    TIME: 3:00 PM EDT
    LOCATION: Virtual
    View Details

    Perspective Therapeutics In-Person and Virtual Analyst Day: Targeted Alpha-Particle Radiotherapy for Cancer

    Join Perspective Therapeutics management for an in-person and virtual analyst day, featuring Richard L. Wahl, MD (Professor of Radiology, Mallinckrodt Institute of…
    TIME: 10:00 AM EDT
    LOCATION: New York Stock Exchange, 11 Wall St, New York, NY 10005
    View Details

    Aligos Therapeutics Virtual KOL Event – Phase 2a HERALD Study of ALG-055009 in MASH

    Join Aligos Therapeutics for a virtual KOL event featuring Stephen Harrison, MD (Visiting Professor, Radcliffe Department of Medicine, University of…
    TIME: 4:00 PM EST
    LOCATION: Virtual
    View Details

    Neurelis Pipeline Update – Advancements to Address Unmet Needs in Neuroscience

    Neurelis will host a 90-minute virtual investor call to highlight updates on two of its product candidates. NRL-1004 for Acute…
    TIME: 10:30 AM EST
    LOCATION: Virtual
    View Details

    Annexon Virtual R&D Day: Guillain-Barré Syndrome – A Focus on the Serious Unmet Need and Annexon’s Novel Therapeutic Approach

    Join Annexon Biosciences for an overview of Guillain-Barré Syndrome (GBS), the most common cause of acute neuromuscular paralysis, featuring GBS…
    TIME: 10:00 AM EST
    LOCATION: Virtual
    View Details

    • Oculis In-Person R&D Day: OCS-01 in Diabetic Macular Edema and OCS-02 in Dry Eye Disease

    Join Oculis in-person or virtually for an R&D Day, featuring multiple ophthalmology experts who will showcase two of Oculis’ clinical…
    TIME: 9:00 AM EST
    LOCATION: InterContinental New York Barclay, 111 E 48th St, New York, NY 10017
    View Details

    TScan Virtual KOL Event to Discuss Updated Results from Phase 1 Heme Malignancies Study and Highlights from the 2024 Tandem Meetings of ASTCT and CIBMTR

    Join TScan Therapeutics for a virtual KOL event, featuring hematologist/oncologists Ran Reshef, MD, MSc (Columbia University Irving Comprehensive Cancer Center) and Monzr M. Al Malki,…
    TIME: 8:00 AM EST
    LOCATION: Virtual
    View Details

    DarioHealth Conference Call

    Access the replay for more information.
    TIME: 8:30 AM EST
    LOCATION: Virtual
    View Details

    Reviva Pharmaceuticals KOL Event to Discuss Topline Data from Phase 3 RECOVER Trial of Brilaroxazine in Schizophrenia

    Join Reviva Pharmaceuticals for a virtual key opinion leader (KOL) event, featuring Larry Ereshefsky, PharmD, BCPP, FCCP (Retired professor of Psychiatry,…
    TIME: 12:00 PM EST
    LOCATION: Virtual
    View Details

    FibroGen Virtual KOL Investor Event Series Part I: Review Pamrevlumab Clinical Program in Pancreatic Cancer and Its Two Near Term Readouts

    Join FibroGen for Part I of a virtual KOL investor event series featuring Andrew Ko, MD (University of California San…
    TIME: 10:30 AM EST
    LOCATION: Virtual
    View Details

    Abivax KOL Investor Event: Review of Phase 2b Clinical Data and Phase 3 Trial Design for Obefazimod in Patients with Moderately to Severely Active Ulcerative Colitis

    Join Abivax for a virtual KOL investor event featuring Marla Dubinsky, MD (Professor of Pediatrics and Medicine, Icahn School of Medicine Mount…
    TIME: 2:00 PM EST
    LOCATION: Virtual
    View Details